Optimal Medical Treatment of Difficult-to-treat Hypertension

Conditions: Hypertension Interventions: Drug: Phase C: Eplerenone; Drug: Phase C: Spironolactone; Drug: Phase C: Torasemide; Drug: Phase B: Triplixam / Elestar HCT; Diagnostic Test: Phase A: Confirmation of uncontrolled hypertension Sponsors: National Institute of Cardiology, Warsaw, Poland Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials